EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vimentin neutralizing antibody ameliorate inflammatory bowel disease by inhibiting fibrosis and inflammatory cell death

Sol Kim, Hye Yeon Kang, Jin-Sil Park, JeongWon Choi, Ha Yeon Jeong, Seon Yeong Lee, Han Hee Lee iD, Bo-In Lee iD, Mi-La Cho iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0352641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Sol Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seou…. Hauptthemen laut MEDLINE: Vimentin, Inflammatory Bowel Diseases, Antibodies, Neutralizing. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD) is characterized by chronic inflammation intertwined with fibrosis and increased necroptosis. Vimentin, an intermediate filament protein closely associated with fibrosis and several inflammatory pathways, is elevated in IBD tissues. We conducted experiments to determine the effect of neutralization of extracellular vimentin with an anti-vimentin antibody (Ab) on the pathogenesis of IBD.

Methods

IBD was mimicked in a 7-week C57BL6 mice by mixing 3% dextran sodium sulfate (DSS) in autoclaved drinking water for five days. A nti-vimentin Ab was intraperitoneally injected with a concentration of 3 milligrams per kilogram repeatedly in a three-day interval simultaneously with DSS administration.

Results

In dextran sodium sulfate (DSS)-induced colitis mice, the anti-vimentin Ab decreased the levels of total and cell-surface vimentin in colon tissues compared to control-treated mice. In DSS-induced colitis mice, treatment with the anti-vimentin Ab improved body weight loss and colon shortening, thereby reducing the severity of DSS-induced colitis. In addition, the anti-vimentin Ab reduced the number of cells expressing fibrosis markers, inflammatory cytokines, and necroptotic markers in colon tissues of DSS-induced colitis mice. In CCD-18CO human colon epithelial cells, the increases in the levels of fibrosis markers caused by TGFβ were enhanced by vimentin protein stimulation and the anti-vimentin Ab reduced the levels of fibrosis-related factors.

Conclusion

This is the first report of the therapeutic effect of an anti-vimentin Ab on the pathogenic mechanisms of IBD. Further studies are needed to confirm its therapeutic potential in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VimentinInflammatory Bowel DiseasesAntibodies, NeutralizingAnimalsMiceFibrosisDextran SulfateMice, Inbred C57BLHumansColitisMaleColonInflammationCell DeathDisease Models, AnimalCytokines

Substanzen

VimentinDextran SulfateAntibodies, NeutralizingCytokines

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Mitochondrial Immunomedicine Center for Global Health Therapeutics (MIGHT), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, Republic of Korea.

ORCID-Profile: Han Hee Lee, Bo-In Lee, Mi-La Cho

Förderung

  • National Research Foundation of Korea
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry

Zitieren

APA

Kim, S., Kang, H. Y., Park, J. S., Choi, J., Jeong, H. Y., Lee, S. Y., Lee, H. H., Lee, B. I., & Cho, M. L. (2026). Vimentin neutralizing antibody ameliorate inflammatory bowel disease by inhibiting fibrosis and inflammatory cell death. PLOS One. https://doi.org/10.1371/journal.pone.0352641

Vancouver

Kim S, Kang HY, Park JS, Choi J, Jeong HY, Lee SY, et al. Vimentin neutralizing antibody ameliorate inflammatory bowel disease by inhibiting fibrosis and inflammatory cell death. PLOS One. 2026. doi:10.1371/journal.pone.0352641

BibTeX
@article{Kim2026,
  author = {Kim, Sol and Kang, Hye Yeon and Park, Jin-Sil and Choi, JeongWon and Jeong, Ha Yeon and Lee, Seon Yeong and Lee, Han Hee and Lee, Bo-In and Cho, Mi-La},
  title = {Vimentin neutralizing antibody ameliorate inflammatory bowel disease by inhibiting fibrosis and inflammatory cell death},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0352641}
}
Kostenlos starten →